The Arkansas Insurance Department (AID) recently asked a federal district judge to dismiss Novo Nordisk’s lawsuit that challenges Arkansas’ state [...] Read More »
Articles by : William Newton, Associate Editor/Senior Writer
Organon, a Merck spinoff with a focus on women’s health, yesterday became the sixth drugmaker to loosen or end its [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Enrollment in the 340B program was linked to diminished spending on charity care, according to preliminary findings from an ongoing [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
GlaxoSmithKline (GSK) today became the fifth drug manufacturer to loosen or end its 340B contract pharmacy restrictions in Arkansas and [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Federal courts should allow enforcement of Arkansas’ 340B contract pharmacy law to continue unimpeded, an attorney representing Arkansas told a [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Rep. Mike Johnson (R-La.), the new speaker of the U.S. House, has received campaign donations from multiple 340B stakeholders but [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A November election for Louisiana attorney general will determine the primary official who both enforces its 340B contract pharmacy law [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Witnesses recently told a U.S. House subcommittee that Congress should cut Medicare payments for 340B drugs. The House Energy and [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
More than 400 hospitals risk losing 340B eligibility if Congress does not extend exemptions authorized during the public health emergency [...] Read More »
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Japanese pharmaceutical manufacturer Eisai will not limit hospital 340B contract pharmacy use in Arkansas and Louisiana after its new contract [...] Read More »